175 related articles for article (PubMed ID: 27670079)
1. The JRC Nanomaterials Repository: A unique facility providing representative test materials for nanoEHS research.
Totaro S; Cotogno G; Rasmussen K; Pianella F; Roncaglia M; Olsson H; Riego Sintes JM; Crutzen HP
Regul Toxicol Pharmacol; 2016 Nov; 81():334-340. PubMed ID: 27670079
[TBL] [Abstract][Full Text] [Related]
2. Review of achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From exploratory testing to test guidelines.
Rasmussen K; González M; Kearns P; Sintes JR; Rossi F; Sayre P
Regul Toxicol Pharmacol; 2016 Feb; 74():147-60. PubMed ID: 26603783
[TBL] [Abstract][Full Text] [Related]
3. The OECD expert meeting on ecotoxicology and environmental fate--towards the development of improved OECD guidelines for the testing of nanomaterials.
Kühnel D; Nickel C
Sci Total Environ; 2014 Feb; 472():347-53. PubMed ID: 24461369
[TBL] [Abstract][Full Text] [Related]
4. Developing OECD test guidelines for regulatory testing of nanomaterials to ensure mutual acceptance of test data.
Rasmussen K; Rauscher H; Kearns P; González M; Riego Sintes J
Regul Toxicol Pharmacol; 2019 Jun; 104():74-83. PubMed ID: 30831158
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy.
Farcal L; Torres Andón F; Di Cristo L; Rotoli BM; Bussolati O; Bergamaschi E; Mech A; Hartmann NB; Rasmussen K; Riego-Sintes J; Ponti J; Kinsner-Ovaskainen A; Rossi F; Oomen A; Bos P; Chen R; Bai R; Chen C; Rocks L; Fulton N; Ross B; Hutchison G; Tran L; Mues S; Ossig R; Schnekenburger J; Campagnolo L; Vecchione L; Pietroiusti A; Fadeel B
PLoS One; 2015; 10(5):e0127174. PubMed ID: 25996496
[TBL] [Abstract][Full Text] [Related]
6. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
[TBL] [Abstract][Full Text] [Related]
7. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies.
Klein CL; Wiench K; Wiemann M; Ma-Hock L; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2012 Jul; 86(7):1137-51. PubMed ID: 22532024
[TBL] [Abstract][Full Text] [Related]
8. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
Warheit DB; Donner EM
Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
[TBL] [Abstract][Full Text] [Related]
9. Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme.
Rasmussen K; Rauscher H; Mech A; Riego Sintes J; Gilliland D; González M; Kearns P; Moss K; Visser M; Groenewold M; Bleeker EAJ
Regul Toxicol Pharmacol; 2018 Feb; 92():8-28. PubMed ID: 29074277
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials in the aquatic environment: A European Union-United States perspective on the status of ecotoxicity testing, research priorities, and challenges ahead.
Selck H; Handy RD; Fernandes TF; Klaine SJ; Petersen EJ
Environ Toxicol Chem; 2016 May; 35(5):1055-67. PubMed ID: 27089437
[TBL] [Abstract][Full Text] [Related]
11. Application of nanomaterials in sample preparation.
Tian J; Xu J; Zhu F; Lu T; Su C; Ouyang G
J Chromatogr A; 2013 Jul; 1300():2-16. PubMed ID: 23611621
[TBL] [Abstract][Full Text] [Related]
12. Translating nanoEHS data using EPA NaKnowBase and the resource description framework.
Mortensen HM; Beach B; Slaughter W; Senn J; Williams A; Boyes W
F1000Res; 2024; 13():169. PubMed ID: 38800073
[TBL] [Abstract][Full Text] [Related]
13. Carbon nanomaterials for advanced energy conversion and storage.
Dai L; Chang DW; Baek JB; Lu W
Small; 2012 Apr; 8(8):1130-66. PubMed ID: 22383334
[TBL] [Abstract][Full Text] [Related]
14. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward.
Landsiedel R; Ma-Hock L; Haussmann HJ; van Ravenzwaay B; Kayser M; Wiench K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):399-413. PubMed ID: 22639437
[TBL] [Abstract][Full Text] [Related]
15. [The use of nanotechnology in medicinal products in the light of European Union law].
Jurewicz M
Pol Merkur Lekarski; 2014 Dec; 37(222):369-72. PubMed ID: 25715580
[TBL] [Abstract][Full Text] [Related]
16. Chemical approaches toward graphene-based nanomaterials and their applications in energy-related areas.
Luo B; Liu S; Zhi L
Small; 2012 Mar; 8(5):630-46. PubMed ID: 22121112
[TBL] [Abstract][Full Text] [Related]
17. Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay.
Kolle SN; Sauer UG; Moreno MC; Teubner W; Wohlleben W; Landsiedel R
Part Fibre Toxicol; 2016 Apr; 13():18. PubMed ID: 27083156
[TBL] [Abstract][Full Text] [Related]
18. FAIRification of nanosafety data to improve applicability of (Q)SAR approaches: A case study on
Bossa C; Andreoli C; Bakker M; Barone F; De Angelis I; Jeliazkova N; Nymark P; Battistelli CL
Comput Toxicol; 2021 Nov; 20():100190. PubMed ID: 34820591
[TBL] [Abstract][Full Text] [Related]
19. Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials.
Ede JD; Lobaskin V; Vogel U; Lynch I; Halappanavar S; Doak SH; Roberts MG; Shatkin JA
Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32599945
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterials: diamondoids display their potential.
Drummond ND
Nat Nanotechnol; 2007 Aug; 2(8):462-3. PubMed ID: 18654338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
